Logo
x

Search

Subscribe Now

Targeted

Boehringer Ingelheim Initiates P-II Study of BI 764198 for Patients with Severe Respiratory Illness from COVID-19

Boehringer Ingelheim Initiates P-II Study of BI 764198 for Patients with Severe Respiratory Illness from COVID-19

  • October 29, 2020
Jazz Collaborates with Redx Pharma to Develop Two Targeted Cancer Therapies

Jazz Collaborates with Redx Pharma to Develop Two Targeted Cancer Therapies

  • September 10, 2020
Sorrento Selects T-VIVA-19 as a Targeted Protein Vaccine Candidate Against COVID-19

Sorrento Selects T-VIVA-19 as a Targeted Protein Vaccine Candidate Against COVID-19

  • July 2, 2020
Merck & Co. Signs an Exclusive Worldwide License Agreement with Taiho and Astex to Develop Targeted Therapies

Merck & Co. Signs an Exclusive Worldwide License Agreement with Taiho and Astex to Develop Targeted Therapies

  • January 6, 2020
Takeda Signs Multi-Target Strategic Collaboration with Prometheus to Develop Targeted Therapies for Inflammatory Bowel Disease

Takeda Signs Multi-Target Strategic Collaboration with Prometheus to Develop Targeted Therapies for Inflammatory Bowel Disease

  • October 7, 2019
Gilead Signs Global Research Collaboration with Tango to Develop & Commercialize Targeted Immuno-Oncology Therapies

Gilead Signs Global Research Collaboration with Tango to Develop & Commercialize Targeted Immuno-Oncology Therapies

  • November 1, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.